Earnings Call · Q2 FY2022·2022-11-07

Q2 22EPS -34.62%·Rev n/aQ1 22EPS -34.78%·Rev n/aQ4 21EPS +7.14%·Rev n/aQ3 21EPS -34.38%·Rev n/a⚠ consensus missing

PETMED EXPRESS INC PETS

Brian Prenoveau — Unknown

Matthew Hulett — CEO

Christine Chambers — CFO

−6.6%1d on move date−7.1% vs SPY3d+0.3%5d−3.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PETS calls or request research access.

More PETS calls Browse calls Request research access